Intranasal saline is effective as a first-line treatment option before considering polysomnography or surgery.
Foralumab stabilized disability for 6 months in all 10 people with nonactive SPMS who took part in an expanded access program, a study found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results